Is Grifols SA halal to invest in?

As of August 2026, Grifols SA GRF.VI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Grifols SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Grifols SA using these criteria to determine its compliance status.

Can Muslims buy shares of Grifols SA?

Muslim investors may consider investing in Grifols SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Grifols SA classified as NOT HALAL?

Musaffa determines the Shariah status of Grifols SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Grifols SA updated?

The Shariah compliance status of Grifols SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Grifols SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Grifols SA?

You can check the latest Shariah compliance status of Grifols SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Grifols SA GRF.VI

Last Updated: Aug 07, 12:00 AM·WBAG

GRF.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Grifols SA is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

Grifols SA. Stock Analysis GRF.VI

Austria Health Care Mid Cap

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 25,258 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.